News Today Logo

Posted 12 Sep 2024

2 min read

It addresses the antibiotic discharge from manufacturing which is recognised as a significant driver of the growing Antimicrobial Resistance (AMR) crisis.

AMR caused by pharmaceutical manufacturing

  • Wastewater generated from antibiotic manufacturing, containing antibiotic residue, pollutes the water bodies like rivers and also seeps into the land.
  • Currently, antibiotic pollution from manufacturing is largely unregulated and quality assurance criteria typically do not address environmental emissions.

About AMR

  • AMR occurs when bacteria, viruses, fungi and parasites no longer respond to antimicrobial medicines. (As per WHO)
  • It is a natural process that happens over time through genetic changes in pathogens. 
  • Its emergence and spread is accelerated by human activity, mainly the misuse and overuse of antimicrobials.
  • The creation of “superbugs” affects healthcare everywhere, but has especially poor outcomes in patients suffering from multiple diseases.

Concerns related to AMR

  • Human and animal health: WHO lists AMR among the top 10 threats for global health. 
    • In 2019, 1.27 million deaths were directly attributed to drug-resistant infections globally.
  • Environment: AMR has a potential to negatively impact biodiversity through pollution and rise of zoonotic diseases.
  • Food and nutrition security: AMR threatens agriculture and animal husbandry. 
  • Economic development and social equity: productivity losses, increased healthcare costs and rise in poverty.

Initiatives to tackle AMR

  • Adopting One Health Approach: Integrated approach aiming at sustainably balancing and optimising health of people, animals and ecosystems.
  • WHO Good Manufacturing Practices (GMP), 2020: Inclusion of environmental aspects of manufacturing linked to waste management etc.
  • National action plan on containment of Antimicrobial Resistance (NAP-AMR), 2017
  • Ban on 40 fixed dose combinations (FDCs) which were found inappropriate.
  • Ban on Colistin as growth promoter in poultry.
  • Development of antimicrobial vaccine, AV0328: Bharat Biotech in collaboration with a US firm.
  • Tags :
  • AMR
  • Pharmaceutical Sector
  • Antimicrobial Resistance
Watch News Today
Width resize handle
Height resize handle

Search Notes

Filter Notes

No notes yet

Create your first note to get started.

No notes found

Try adjusting your search criteria.

Subscribe for Premium Features